Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
08/19/1995 | CA2142513A1 Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease |
08/19/1995 | CA2142315A1 Drug |
08/17/1995 | WO1995021857A1 Novel 2-substituted indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
08/17/1995 | WO1995021855A1 Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase |
08/17/1995 | WO1995021854A1 Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace |
08/17/1995 | WO1995021843A1 Azacyclic derivatives |
08/17/1995 | WO1995021840A1 Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase |
08/17/1995 | WO1995021839A1 Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
08/17/1995 | WO1995021838A1 Pyridyl imidazole derivatives and processes for the preparation thereof |
08/17/1995 | WO1995021832A1 Pharmaceutical piperazine compounds |
08/17/1995 | WO1995021819A1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists |
08/17/1995 | WO1995021811A1 Novel benzylaminoethoxybenzene derivative, process for producing the same, and use thereof |
08/17/1995 | WO1995021613A1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
08/17/1995 | WO1995021612A2 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
08/17/1995 | WO1995021608A1 Use of insulin sensitisers for treating renal diseases |
08/17/1995 | WO1995021601A2 Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof |
08/17/1995 | CA2182986A1 Use of insulin sensitisers for treating renal diseases |
08/17/1995 | CA2182877A1 Pharmaceutical piperazine compounds |
08/17/1995 | CA2182734A1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists |
08/17/1995 | CA2182680A1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
08/17/1995 | CA2180006A1 Diastereomeric pure trifluoromethyl ketone peptide derivatives as inhibitors of human leukocyte elastase |
08/17/1995 | CA2160591A1 Protein having tpo activity |
08/17/1995 | CA2160019A1 Novel benzylaminoethoxybenzene derivatives, production thereof and use thereof |
08/17/1995 | CA2142535A1 1-[2-(1h-inden-3-yl)ethyl]-4- (naphth-1-yl)piperazine derivatives, their preparation and their application in therapeutics |
08/16/1995 | EP0667347A1 Beta-carboline thromboxane synthase inhibitors |
08/16/1995 | EP0667342A1 Substituted Arylureas and their use as anti-atheriosclerotic compounds |
08/16/1995 | EP0667341A1 4-Amino-1-piperidylbenzoylguanidines as Na+/H+ antiporter inhibitors |
08/16/1995 | EP0667340A1 Isatine derivates, their preparation and their use as excitatory amino acid receptor antagonist |
08/16/1995 | EP0666914A1 Novel p-selectin ligand protein |
08/16/1995 | EP0666906A1 Cho cells expressing human endothelin receptors |
08/16/1995 | EP0666858A1 5-arylindole derivatives and their use as serotonin (5-ht 1?) agonists |
08/16/1995 | EP0666856A1 4-arylmethyloxymethyl piperidines as tachykinin antagonists |
08/16/1995 | EP0666850A1 1,2,3,5,6,7,8,8a-OCTAHYDRO-5,5,8a-TRIMETHYL-(8a-g(b))-6-ISOQUINOLINEAMINE DERIVATIVES, PREPARATION METHOD THEREFOR AND THERAPEUTICAL USE THEREOF. |
08/16/1995 | EP0666849A1 Aryl and heteroarylmethoxyphenyl inhibitors of leukotriene biosynthesis |
08/16/1995 | EP0666758A1 Anti-inflammatory tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides |
08/16/1995 | EP0666757A1 Anti-inflammatory, tolerogenic and immunostimulatory properties of carbohydrate binding-proteins |
08/16/1995 | EP0666747A1 USE OF 17$g(a)-DIHYDROEQUILENIN FOR LOWERING CHOLESTEROL |
08/16/1995 | EP0666741A1 Dithiocarbamates for the treatment of atherosclerosis and other cardiovascular and inflammatory diseases |
08/16/1995 | EP0588839B1 Nitroglycerine patch and process for making it |
08/16/1995 | EP0418308B1 Recombinant techniques for production of novel natriuretic and vasodilator peptides |
08/16/1995 | CN1106812A Tricyclic diazepine vasopressin antagonists |
08/16/1995 | CN1106811A Piperidines and piperazines |
08/16/1995 | CN1106806A Adhesion receptor antagonists |
08/16/1995 | CN1106805A Sulfonamide endothelin antagonists |
08/16/1995 | CN1106804A 1-Benzenesulfonyl-1,3-dihydro-2H-benzimidazol-2-one derivatives |
08/16/1995 | CN1106802A Tricyclic benzazepine vasopressin antagonists |
08/16/1995 | CN1106663A Thienopyrimidine derivatives, their production and use |
08/15/1995 | US5442120 Production of dobutamine compounds |
08/15/1995 | US5442064 Anticoagulants, antiagglomerants |
08/15/1995 | US5442008 Stabilized polymer film coated compounds and stabilized formulations in compressed from using same |
08/15/1995 | US5441986 Estrogen agonists as remedies for prostate and cardiovascular diseases |
08/15/1995 | US5441976 Immunostimulants |
08/15/1995 | US5441975 Anticholesterol agent |
08/15/1995 | US5441969 Imidazole compounds, their preparation and use |
08/15/1995 | US5441967 Cyclic amine compounds and their use |
08/15/1995 | US5441962 Administering isoquinolinone derivatives |
08/15/1995 | US5441960 1-pyrimidinylacetamide human leukocyte elastate inhibitors |
08/15/1995 | US5441959 Hypotensive agents; treating congestive heart failure and glaucoma,inhibiting restenosis |
08/15/1995 | US5441948 1,3,4-benzotraizepin-5(4H)-one derivatives and process for the preparation thereof |
08/15/1995 | US5441947 Administering wortmannin |
08/15/1995 | CA1336711C Lactam derivatives, their preparation and their use as hypotensive agents |
08/11/1995 | CA2142070A1 4-amino-1-piperidylbenzoylguanidines |
08/10/1995 | WO1995021194A1 Superactive vip antagonists |
08/10/1995 | WO1995021180A1 Substituted lactose derivatives as cell adhesion inhibitors |
08/10/1995 | WO1995020979A1 Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis |
08/10/1995 | WO1995020950A1 Therapeutic guanidines |
08/10/1995 | WO1995017876A3 2,4-disulphophenyl butylnitrone, its salts, and their use as pharmaceutical spintraps |
08/10/1995 | CA2182731A1 Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis |
08/10/1995 | CA2182302A1 Therapeutic guanidines |
08/10/1995 | CA2182007A1 Substituted lactose derivatives as cell adhesion inhibitors |
08/09/1995 | EP0666260A1 3-(2-aminoethyl)-4-3-(trifluoromethyl)benzoyl-3,4-dihydro-2H-1,4-benzoxazine derivatives, their preparation and use in therapy |
08/09/1995 | EP0666252A1 Phenyl substituted alkyl carboxylic acid guanidines with perfluoroalkyl groups, process for their preparation, their use as medicament or diagnostic agent as well as medicament containing the same |
08/09/1995 | EP0666250A1 Derivatives of N-(3-aminopropyl)-N-phenyl-5,6,7,8-tetrahydronaphthalene-2-carboxamide having neuroprotective and anti-ischemic properties, their preparation and their use, in therapy |
08/09/1995 | EP0665842A1 Sulfonamide derivatives of benzenefused hydroxy substituted cycloalkyl and heterocyclic ring compounds |
08/09/1995 | EP0601123B1 Low speed model following velocity command system for rotary wing aircraft |
08/09/1995 | CN1106611A Substituted phosphonates, the processes for their preparation and pharmaceutical compositions containing them |
08/09/1995 | CN1106388A 1,2-dihydro-2-oxo-pyridine |
08/09/1995 | CN1106387A 1,2-dihydro-2-oxo-3-methyl-sulfonylaminomethyl-pyridine |
08/09/1995 | CN1106381A Orthosubstituted benzoylguanidine, preparation of same, pharmaceutical containing same and application of same |
08/09/1995 | CN1106368A Triterpene derivatives and endothelin-receptor antagonists containing the same |
08/08/1995 | US5440054 Analogs of amiodarone; cyclization of salicylaldehyde to benzofuran acetic acid; iodination, esterification, amination hydrolysis, salt formation |
08/08/1995 | US5440046 Angiotensin antagonist, hypotensive agent |
08/08/1995 | US5440036 1,4-benzoxazine derivatives |
08/08/1995 | US5440035 Leukotriene antagonists; antiallergens, antiinflammatory agents |
08/08/1995 | US5440019 Processes of producing amylase inhibitors |
08/08/1995 | US5439927 For potassium channel opening, hypotensive agents, broncho- or vasodilators, gastrointestinal disorders |
08/08/1995 | US5439914 Spirocycles |
08/08/1995 | US5439909 2-Substituted with amide or thioamide group; antioxidant for lipoproteins, antilipemic agents, anticholesterol agents |
08/08/1995 | US5439906 Antiarrhythmic benzodiazepines |
08/08/1995 | US5439895 4-aminoquinazoline derivatives |
08/08/1995 | US5439887 Peptide having antihypertensive activity free of vascoconstrictor activity |
08/08/1995 | US5439820 Anti-thrombin polypeptides |
08/04/1995 | CA2141729A1 N-(3-aminopropyl)-n-phenyl-5,6,7,8-tetrahydro-naphthalene -2-carboxamide derivatives, their preparation and their therapeutic use |
08/04/1995 | CA2141728A1 3-(2-aminoethyl)-4-¬3-(trifluoromethyl)benzoyl|-3, 4-dihydro-2h-1,4- benzoxazine derivatives, process for their preparation and their therapeutic application |
08/03/1995 | WO1995020581A1 Novel human leukocyte elastase (hle) inhibitors, and related pharmaceutical compositions and methods of use |
08/03/1995 | WO1995020579A1 Cyanoguanidines as k-channel blockers |
08/03/1995 | WO1995020578A1 SUBSTITUTED AROMATIC COMPOUNDS AS c.AMP PHOSPHODIESTERASE- AND TNF-INHIBITORS |
08/03/1995 | WO1995020576A1 4-(2-(3-aryloxy-2-hydroxypropylamino alkyloxy)-5-nitrophenyl)-1,4-dihydropyridines as antihypertensive agents |
08/03/1995 | WO1995020575A1 Aralkylamino substituted azacyclic therapeutic agents |
08/03/1995 | WO1995020571A1 A pharmaceutical product comprising a salicylate of an esterifiable ace-inhibitor |